EMA Lifts Restriction on Valneva’s Chikungunya Vaccine for Elderly, Balancing Risks and Benefits
The European Medicines Agency (EMA) has lifted its temporary restriction on Valneva’s chikungunya vaccine, IXCHIQ, for individuals aged 65 and above, allowing its use in vulnerable populations.
2 minutes to read